Search Results for "Hydrocodone Bitartrate 7 5 Mg"

05:30 EDT 25th October 2014 | BioPortfolio

Matching Channels

None

Matching News

FDA grants Priority Review designation for Purdue’s hydrocodone bitartrate

Privately held US drugmaker Purdue Pharma has been granted Priority Review designation by the US Food and Drug Administration for its once-daily, single-entity hydrocodone bitartrate tablet.

Purdue gets FDA priority review designation for hydrocodone bitartrate tablets

The US Food and Drug Administration (FDA) has granted priority review designation for US-based Purdue Pharma's hydrocodone bitartrate extended-release tablets for treatment of chronic pain.

Purdue’s hydrocodone bitartrate tablets granted priority review designation

Purdue Pharma has been granted priority review designation by the US Food and Drug Administration (FDA) for its hydrocodone bitartrate extended-release tablets for treatment of chronic pain.

Update on Tamper-Proof Hydrocodone Products

Purdue and Zogenix report their progress in gaining approval for formulations of single-entity hydrocodone bitartrate that are difficult to misuse or abuse. Medscape Medical News

Novel Hydrocodone: 24-Hour Analgesia, Less Abuse Potential

Once-daily, extended-release hydrocodone bitartrate provides persistent pain relief in patients with chronic nonmalignant and nonneuropathic pain and also comes with abuse-deterrent properties. Meds...

Hydrocodone bitartrate ER regulatory update

Hydrocodone bitartrate ER: Clinical trial data

Vycavert hydrocodone bitartrate/acetaminophen regulatory update

Matching PubMed Articles

Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Infantile neuronal ceroid lipofuscinosis is a devastating neurodegenerative lysosomal storage disease caused by mutations in the gene (CLN1 or PPT1) encoding palmitoyl-protein thioesterase-1 (PPT1). W...

DEA Tightens Restrictions on Hydrocodone Combination Products.

Rescheduling of hydrocodone combination products.

Extended-release hydrocodone (Zohydro) for pain.

Observation of improved adherence with frequent urine drug testing in patients with pain.

To determine the relationship between urine drug testing (UDT) frequency and patient adherence for prescribed buprenorphine, carisoprodol, fentanyl, hydrocodone, methadone, morphine, and oxycodone.

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement